Cannabis Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export 

Expanding Horizons of the Cannabis Market 

The Cannabis Market is witnessing unprecedented transformation, driven by changing regulatory frameworks, consumer acceptance, and growing therapeutic applications. For instance, countries such as Germany, Canada, and Thailand have accelerated medical cannabis approvals, fueling a significant surge in cultivation and product innovation. According to Datavagyanik, the global Cannabis Market is experiencing a compound annual growth rate (CAGR) exceeding 20% between 2024 and 2030, highlighting the strong momentum behind this sector. Expanding legalization frameworks and a robust medical cannabis pipeline are enabling producers to tap new revenue streams across both medical and recreational segments, thereby reshaping the competitive landscape of the Cannabis Market. 

Evolving Consumer Preferences Reshape the Cannabis Market 

Consumer patterns are shifting rapidly within the Cannabis Market, creating immense opportunities for product diversification. For instance, premium cannabis products such as edibles, vapes, and beverages are experiencing exponential growth. According to Datavagyanik, the cannabis-infused beverage category alone is projected to grow at over 17% CAGR through 2030, as consumers increasingly seek alternatives to alcoholic drinks with perceived health benefits. Moreover, cannabis wellness products infused with cannabidiol (CBD) are penetrating skincare, nutraceutical, and sports recovery markets, indicating a broadening of cannabis demand beyond recreational use. This structural change in consumer behavior supports premiumization strategies and cross-segment innovations within the Cannabis Market. 

Regulatory Shifts Drive Expansion in the Cannabis Market 

Regulatory tailwinds continue to be a cornerstone of growth in the Cannabis Market. For instance, legislative reforms in the United States, such as the SAFE Banking Act, are improving access to financial services for cannabis operators, lowering systemic risks, and encouraging investment inflows. Simultaneously, several Latin American nations are creating pathways for legal cultivation to stimulate rural employment and export potential. Datavagyanik indicates that by 2027, over 50% of global cannabis supply is expected to originate from legally regulated frameworks, compared to less than 20% in 2019. This transition supports structured growth, improves product safety, and reduces illicit trade, thereby strengthening the global Cannabis Market. 

Technological Innovations Transforming the Cannabis Market 

Technology is a decisive factor powering efficiencies across the Cannabis Market value chain. For example, precision agriculture tools such as smart irrigation, data-driven pest management, and genetic crop optimization are enhancing yields while minimizing environmental footprints. Automated trimming machines and robotic packaging systems are reducing labor costs by up to 30% for large-scale operators, according to Datavagyanik. Furthermore, blockchain-based track-and-trace solutions are enabling transparent, compliant supply chains, which are vital for highly regulated medical cannabis exports. Such innovations are not only boosting profitability but also improving trust and traceability in the Cannabis Market, thereby attracting more institutional investors. 

Medical Cannabis Market Demand Surges with Clinical Progress 

Medical applications continue to be a prime driver for the Cannabis Market. For instance, cannabinoid-based therapies are being explored for conditions ranging from chronic pain and epilepsy to multiple sclerosis and PTSD. Datavagyanik estimates the medical cannabis segment will account for nearly 55% of the global Cannabis Market by 2030, supported by robust clinical pipelines and the growing acceptance of cannabis-based formulations in mainstream healthcare. Notably, the number of registered medical cannabis patients in the United States has grown from 3 million in 2016 to over 7 million by 2024, demonstrating a broadening therapeutic user base. This expanding patient population, combined with regulatory approvals for rare-disease indications, is expected to sustain double-digit growth across the medical Cannabis Market. 

Rising Investments Reshape the Cannabis Market Competitive Landscape 

Capital flows into the Cannabis Market have reached historic highs, with both institutional and retail investors taking positions in vertically integrated cannabis companies. For example, mergers and acquisitions are driving economies of scale and accelerating market entry strategies across emerging cannabis economies. Datavagyanik notes that deal volumes in the global Cannabis Market exceeded USD 15 billion in 2024 alone, highlighting significant confidence in this rapidly evolving sector. Such funding activity is helping companies expand cultivation capacity, invest in advanced processing technologies, and strengthen global distribution networks. The resulting market consolidation is reshaping competitive dynamics and elevating product quality and brand differentiation within the Cannabis Market. 

Cannabis Market Size Expands with Global Trade Opportunities 

The Cannabis Market Size is poised to expand dramatically as cross-border trade barriers continue to fall. For instance, the United Kingdom, Australia, and Germany have actively liberalized import policies for medical cannabis, creating lucrative opportunities for exporters in Latin America and Africa. Datavagyanik suggests that the international cannabis trade could grow at over 22% CAGR through 2030, unlocking new economic value chains while empowering developing economies to participate in the global Cannabis Market. Moreover, these cross-border linkages are expected to drive product standardization, improve compliance, and encourage harmonized quality certifications, thus enhancing global consumer trust. 

Industrial Hemp Reinforces Growth of the Cannabis Market 

Industrial hemp cultivation is another critical growth pillar of the Cannabis Market. For instance, hemp-derived products such as textiles, bioplastics, construction materials, and dietary supplements are experiencing a revival as sustainable alternatives to conventional resources. Datavagyanik indicates industrial hemp acreage expanded by more than 200% between 2019 and 2024 in North America alone, driven by growing interest in low-carbon solutions. As sustainability imperatives strengthen worldwide, hemp’s versatility will likely become a strategic differentiator within the Cannabis Market, offering producers diversified revenue streams beyond high-THC cannabis strains. 

Shifting Social Norms Accelerate Cannabis Market Acceptance 

Changing cultural perceptions are playing a vital role in mainstreaming the Cannabis Market. For example, younger generations are increasingly associating cannabis consumption with wellness and social experience rather than countercultural rebellion. Datavagyanik highlights that cannabis usage rates among consumers aged 21 to 34 have grown by nearly 30% over the past five years, underscoring a demographic shift that bodes well for long-term market sustainability. This normalization of cannabis aligns with the expanding retail footprint of dispensaries, cafes, and social lounges, which are reshaping the urban consumer landscape. The result is a powerful cultural momentum supporting the broader Cannabis Market expansion. 

Regional Diversification Enhances Resilience of the Cannabis Market 

Regional diversification is becoming a strategic priority in the Cannabis Market as stakeholders seek to mitigate regulatory and supply chain risks. For instance, cannabis cultivation is expanding in Morocco, Lesotho, and Colombia, creating an emerging global footprint and reducing over-reliance on North American production. Datavagyanik expects regional diversification to deliver more resilient supply chains and stimulate local economic growth, particularly in underserved rural areas. By building regional competencies in cultivation, processing, and distribution, stakeholders can fortify their positions in a globally interconnected Cannabis Market, thereby supporting long-term industry resilience. 

Cannabis Market Size Benefits from Product Innovation 

Product innovation is a central catalyst in growing the Cannabis Market Size. For example, fast-acting sublingual sprays, nanoemulsion-based edibles, and extended-release capsules are enhancing consumer convenience and improving bioavailability. Datavagyanik indicates that cannabis edibles alone could exceed USD 10 billion in annual sales by 2030, as consumers seek more discreet and controlled consumption formats. These innovations are enabling broader consumer adoption across age groups and socio-economic segments, thereby expanding addressable markets for cannabis companies. Innovation-led differentiation is expected to be a major driver of competitive advantage within the global Cannabis Market. 

Future Outlook of the Cannabis Market 

Looking ahead, the Cannabis Market is expected to sustain its high-growth trajectory as legalization advances, technological adoption deepens, and global trade frameworks mature. For instance, regional free-trade agreements and harmonized standards could unlock new markets for cannabis-infused products, while improved clinical evidence may strengthen medical cannabis acceptance. Datavagyanik anticipates that the Cannabis Market will continue evolving into a multi-billion-dollar ecosystem spanning pharmaceuticals, nutraceuticals, industrial hemp, and recreational segments. Stakeholders who strategically invest in quality, compliance, and innovation are well-positioned to capture the next wave of growth opportunities in this dynamic Cannabis Market landscape. 

 

“Track Country-wise Cannabis Production and Demand through our Database”

• • • Cannabis sales volume database for 27+ countries worldwide

 

Geographical Demand Dynamics Transform the Cannabis Market 

Regional patterns of demand are reshaping the Cannabis Market in striking ways. For instance, North America remains the largest market due to its mature regulatory ecosystem and strong consumer base. Datavagyanik highlights that nearly 75% of legal global cannabis sales in 2024 originated in the United States and Canada, demonstrating the outsized influence of North America on global Cannabis Market trajectories. In parallel, Europe is advancing steadily with countries such as Germany, the Czech Republic, and Portugal driving medical cannabis adoption, backed by more than 60% growth in prescription volumes year-over-year. Meanwhile, Asia-Pacific is expected to witness the fastest growth rate, exceeding 30% CAGR through 2030, supported by changing policies in Thailand, Japan, and South Korea. This shifting global geography creates diverse opportunities for Cannabis Market stakeholders to design region-specific portfolios and pricing strategies. 

Emerging Economies Strengthen Cannabis Market Participation 

Emerging economies are increasingly stepping into the Cannabis Market as production and consumption hubs. For example, Latin America is witnessing a transformation, with Colombia, Uruguay, and Argentina leveraging their climate advantages and lower cultivation costs to develop competitive cannabis export industries. Datavagyanik projects Latin America’s share in global cannabis exports will expand from 5% in 2022 to nearly 18% by 2030, driven by liberalized laws and international trade partnerships. Africa is also showing promise, with nations such as Lesotho, Zimbabwe, and South Africa establishing commercial licenses for cannabis cultivation to unlock rural development and foreign exchange earnings. These emerging economies are strengthening their Cannabis Market presence by aligning legal frameworks with global demand growth, adding resilience and inclusivity to the global cannabis value chain. 

Advanced Cannabis Manufacturing Optimizes the Cannabis Market 

Innovation in Cannabis Manufacturing is accelerating to support the scaling of the Cannabis Market. For example, large greenhouses with advanced environmental controls are delivering up to 40% higher yields compared to traditional outdoor farming. Datavagyanik emphasizes the importance of automated harvesting and drying systems, which are minimizing post-harvest losses and improving product consistency. Extraction techniques such as CO2 supercritical extraction and ethanol-based methods are advancing to achieve over 90% cannabinoid recovery, enabling manufacturers to develop high-quality isolates and distillates for medical and recreational markets. Such Cannabis Manufacturing upgrades are lowering costs, enhancing regulatory compliance, and empowering producers to introduce differentiated products that match evolving consumer expectations in the Cannabis Market. 

Regional Hubs Foster Cannabis Manufacturing Leadership 

Specific regions are emerging as specialized hubs for Cannabis Manufacturing within the Cannabis Market. For instance, British Columbia in Canada has consolidated advanced cultivation facilities and high-capacity processing plants that supply both domestic and international markets. Similarly, California’s Central Valley has developed vertically integrated Cannabis Manufacturing ecosystems, supported by a skilled agricultural workforce and a strong technology supply base. In Europe, Portugal is rapidly becoming a preferred Cannabis Manufacturing location due to its favorable climate, relatively low labor costs, and harmonized EU standards, giving it an edge to serve the wider European Cannabis Market. Datavagyanik expects these hubs to grow into globally recognized centers of excellence, setting benchmarks for quality, safety, and sustainability in cannabis production. 

Market Segmentation Drives Innovation in the Cannabis Market 

Segmentation across product types is becoming sharper within the Cannabis Market. For example, dried flower products accounted for nearly 45% of the global market in 2024, supported by their cultural familiarity and lower cost. However, concentrates and extracts are gaining ground, growing at 18% CAGR, as consumers look for higher potency and alternative consumption methods. Edibles are another rapidly evolving segment, projected to surpass USD 10 billion in annual sales by 2030, driven by discreet usage and a more precise dosage profile. Datavagyanik notes that medical cannabis formulations now account for over 50% of the global Cannabis Market, boosted by expanding therapeutic approvals and broader patient acceptance. This nuanced segmentation is reshaping brand strategies, encouraging targeted marketing, and enabling differentiated pricing models across the Cannabis Market. 

Industrial Applications Expand Cannabis Market Horizons 

Beyond recreational and medical uses, the industrial segment is adding a dynamic layer to the Cannabis Market. For example, hemp fibers are increasingly used in textile manufacturing, with market demand growing at nearly 15% CAGR due to eco-friendly consumer preferences. Hemp-based bioplastics are forecast to achieve over 20% annual growth through 2030 as industries seek low-carbon alternatives to traditional polymers. Datavagyanik points out that hempseed oil and protein powders are establishing strong niches within functional foods and supplements, expanding the industrial Cannabis Market footprint. These applications provide important diversification opportunities for cultivators and processors, reducing overreliance on THC-driven products and creating more resilient business models. 

Price Trends Reshape the Cannabis Market Landscape 

Pricing patterns are undergoing fundamental shifts across the Cannabis Market. For instance, oversupply in North America has driven down wholesale cannabis flower prices by nearly 40% between 2020 and 2024, according to Datavagyanik, compelling producers to adopt more efficient Cannabis Manufacturing techniques to protect margins. In Europe, medical cannabis prices remain higher due to tighter regulatory supply, with average retail prices between USD 8 to 12 per gram, depending on THC potency and GMP certification. Asia-Pacific markets are experiencing premium price brackets for imports, often exceeding USD 15 per gram, as local production is still ramping up. This price segmentation encourages innovation in formulations, branding, and retail experiences to capture value beyond raw commodity pricing in the Cannabis Market. 

Value-Added Manufacturing Enhances Cannabis Market Profitability 

Cannabis Manufacturing is moving from commodity-oriented production to value-added processing, allowing stakeholders to command premium prices. For instance, microencapsulation technology is being applied to develop water-soluble cannabinoids for beverages, improving bioavailability and enabling stable shelf-life. Datavagyanik observes that companies employing nanoemulsion processes are achieving cannabinoid absorption rates 3 to 5 times higher than traditional oils, creating a compelling value proposition in the Cannabis Market. Advanced terpene reconstitution is also emerging, allowing producers to tailor flavor profiles and enhance consumer experiences. These Cannabis Manufacturing capabilities drive profitability and support branding efforts that can sustain higher price points, even in competitive markets. 

Cannabis Market Adopts Circular Manufacturing Practices 

Sustainability is becoming a core priority across Cannabis Manufacturing operations, further strengthening the Cannabis Market. For example, closed-loop water recycling systems can reduce water consumption by up to 80%, a critical advantage in water-stressed regions such as California. Energy-efficient LED grow lights are slashing power bills by nearly 35%, while organic pest control methods help meet consumer preferences for cleaner, pesticide-free products. Datavagyanik forecasts that cannabis companies adopting circular manufacturing models will improve cost structures and brand trust, allowing them to secure long-term contracts with medical institutions and global wellness brands. These practices are setting new standards for environmental stewardship within the Cannabis Market. 

Regional Trade Agreements Boost Cannabis Market Growth 

The Cannabis Market is benefiting from emerging trade agreements that support the movement of cannabis goods across borders. For example, the European Union has streamlined GMP certification recognition, allowing medical cannabis products to circulate more easily between member states. Datavagyanik highlights that Latin American free trade frameworks are helping Colombia, Uruguay, and Peru expand exports to European and North American buyers, projected to grow regional cannabis export revenues by more than 25% annually through 2030. As global harmonization of quality standards accelerates, manufacturers are better positioned to scale Cannabis Manufacturing operations and secure consistent access to international markets, driving volume and stability within the Cannabis Market. 

Customization Trends Drive Cannabis Market Differentiation 

Product customization is fast emerging as a growth strategy within the Cannabis Market. For instance, tailored cannabinoid ratios such as CBD:THC blends, terpene-infused products, and strain-specific formulations are resonating with experienced consumers who demand precision and personalization. Datavagyanik expects this trend to drive product line expansions, as companies develop formulations for sleep, pain relief, focus, or energy, thereby creating specialized niches. Cannabis Manufacturing processes are adapting to these requirements through flexible batch production lines and advanced laboratory testing to meet diverse demand profiles. These customization capabilities are cementing brand loyalty and improving repeat purchase rates, strengthening revenue streams in the Cannabis Market. 

Automation and Digitalization Advance the Cannabis Market 

The Cannabis Market is rapidly digitizing to improve manufacturing precision and compliance. For example, AI-based cultivation systems can monitor growth cycles in real time, optimizing lighting, humidity, and nutrient delivery to boost yields. Datavagyanik indicates that facilities implementing robotics for trimming and sorting are lowering labor costs by over 25% while maintaining consistent product quality. Blockchain-enabled track-and-trace systems are improving inventory transparency and regulatory reporting, essential for cross-border cannabis shipments. These digital enablers are elevating Cannabis Manufacturing standards and ensuring traceability, which is critical for the trust and growth of the Cannabis Market. 

Future of Cannabis Manufacturing Secures Cannabis Market Scalability 

The future of Cannabis Manufacturing is increasingly defined by precision, scale, and sustainability, creating a strong foundation for the Cannabis Market to flourish. For example, pharmaceutical-grade production facilities are implementing cleanroom standards, enabling consistent and high-quality output for medical cannabis formulations. Datavagyanik forecasts that advanced GMP-certified sites will expand by more than 40% globally between 2024 and 2028, ensuring a robust medical-grade supply chain. Integration of machine learning algorithms for predictive maintenance and quality control will further enhance output consistency. These advanced Cannabis Manufacturing models are unlocking economies of scale and reinforcing the global Cannabis Market with reliable, standardized products. 

Price Stabilization Expected in the Cannabis Market 

Looking forward, Datavagyanik expects pricing volatility in the Cannabis Market to ease as global supply chains mature and Cannabis Manufacturing capabilities expand. For instance, price corrections in oversupplied North American regions are already showing signs of stabilizing, while new cultivation hubs in Africa and Latin America are entering the market with cost-competitive products. These shifts are projected to create a more predictable pricing environment for both raw materials and value-added cannabis products. This stabilization will support long-term investment planning and encourage steady growth trajectories within the Cannabis Market, benefiting stakeholders across the ecosystem. 

Strategic Collaborations Strengthen the Cannabis Market 

Collaborations are emerging as a strategic lever to advance the Cannabis Market. For instance, partnerships between biotech firms and cannabis cultivators are driving breakthroughs in genetics, improving plant resilience and cannabinoid yield. Datavagyanik highlights that collaborations between medical research organizations and cannabis manufacturers are speeding up clinical trials, supporting faster approvals of cannabinoid therapies. Moreover, global alliances are emerging to harmonize regulatory frameworks and quality standards, ensuring seamless trade flows and mutual recognition of product certifications. These alliances will accelerate Cannabis Manufacturing innovation and reinforce trust in the broader Cannabis Market, creating a stable foundation for continued expansion. 

“Cannabis Manufacturing Database”

• • • Cannabis top manufacturers market share for 27+ manufacturers
    • Top 7 manufacturers and top 17 manufacturers of Cannabis in North America, Europe, Asia Pacific
    • Cannabis sales dashboard, Cannabis sales data in excel format

 

Top Manufacturers Driving the Cannabis Market 

The Cannabis Market is commanded by a handful of powerful manufacturers that continue to scale operations through strategic acquisitions, innovative product portfolios, and targeted consumer engagement. Curaleaf stands at the forefront with extensive retail networks and integrated cultivation, processing, and distribution capabilities. Its broad product offerings, including flower, pre-rolls, extracts, and the Select oils line, have consolidated its leadership in both medical and adult-use segments. 

Green Thumb Industries holds a significant presence, capturing growing market share through branded dispensaries and strong products such as &Shine flower and Beboe vape pens. The company’s robust multistate network allows it to cater to diverse consumer segments, while its investment in product innovation has elevated brand recognition. 

Tilray has emerged as a global force, particularly in the medical Cannabis Market, supported by a wide portfolio of pharmaceutical-grade cannabis extracts and dried flower products. Its acquisition of Aphria has broadened its European footprint, enabling access to emerging medical cannabis patients while leveraging a strong distribution infrastructure. 

Canopy Growth has built a recognizable brand presence with product lines including Tweed and Tokyo Smoke, focusing on premium flower and oil formulations. Despite competitive pressures, Canopy Growth remains a top-tier manufacturer due to its consistent investments in cultivation quality, brand partnerships, and global expansion strategies. 

Aurora Cannabis, known for its Aurora Sky facility and large-scale production, has prioritized high-quality oils and concentrates. The company has deployed advanced growing and harvesting technologies to maintain product consistency and expand its share in therapeutic applications. 

Trulieve has reinforced its market share with a regional focus, primarily in Florida and other states, expanding rapidly through acquisitions. Its portfolio includes flower, tinctures, and concentrates, supported by a loyal consumer base and a high-volume dispensary model. 

Organigram is rapidly climbing the ranks, leveraging a series of acquisitions to build market share in Canada. Its focus on extracts, vape cartridges, and high-potency pre-rolls has helped capture a premium niche while strengthening its production capacity. 

 

Manufacturer Market Share in the Cannabis Market 

Despite these strong leaders, the Cannabis Market remains fragmented. Curaleaf maintains the largest single share, yet it still commands under 10 percent of total market volume due to strict regulatory frameworks and high product diversity. Green Thumb Industries, Tilray, and Trulieve collectively represent another 15 to 20 percent of the global Cannabis Market, with most of their market share concentrated in North America. 

Canopy Growth and Aurora Cannabis have solidified their positions but are under pressure to maintain profitability as competition intensifies and wholesale prices fluctuate. Organigram’s recent expansion pushes its Canadian market share to approximately 5 percent, aiming to close the gap with the bigger players. 

Overall, these top manufacturers together account for roughly 35 percent of global Cannabis Market revenue, indicating significant opportunities for growth and consolidation. Small and medium producers still dominate many state and regional markets, especially in flower sales, where local licensing often restricts national penetration. 

 

Cannabis Market Product Portfolios Among Leading Manufacturers 

Curaleaf’s broad portfolio includes its flagship Select oil cartridges and high-quality BlueKudu edibles, providing a differentiated consumer experience while leveraging scale advantages in cultivation. Green Thumb Industries has built a strong presence in the premium flower category through its &Shine brand, while Beboe serves the luxury vaping segment with high-end design and curated terpene blends. 

Tilray focuses heavily on medical-grade extracts, oral sprays, and GMP-compliant dried flower, meeting pharmaceutical distribution requirements across Europe and beyond. Its position in the therapeutic cannabis sector is reinforced by clinical-grade cultivation processes. 

Canopy Growth continues to innovate around its Tweed and Tokyo Smoke brands, offering both high-THC and balanced CBD strains. Edibles, beverages, and softgels under these labels extend its reach into emerging consumer categories beyond traditional flower. 

Aurora Cannabis maintains a diverse mix of dried flower, full-spectrum extracts, and innovative sublingual formulations. Its manufacturing capacity, driven by advanced greenhouse operations, allows consistent output for both recreational and medical buyers. 

Trulieve’s product line includes a broad flower range, vapes, concentrates, and tinctures, supported by large in-house cultivation and a vertically integrated dispensary model that delivers high product turnover. 

Organigram is investing in premium extracts and fast-acting vape products, with its new manufacturing investments designed to meet increasing consumer demand for potency, quality, and consistency. 

 

Recent Trends in Manufacturer Strategies Within the Cannabis Market 

Manufacturers in the Cannabis Market are increasingly shifting their focus from quantity to quality, driven by rising consumer expectations and price pressures. Premiumization is evident across most leading brands, with advanced formulations such as nanoemulsions, water-soluble cannabinoids, and terpene-enhanced products becoming popular. These innovations allow companies to defend higher price points and sustain margins even in oversupplied markets. 

Meanwhile, many operators are strengthening their medical cannabis portfolios, anticipating that regulatory approvals for more conditions will open fresh demand. The push toward medical-grade cultivation and pharmaceutical distribution is also helping companies build brand trust with healthcare professionals and patients. 

Manufacturers are investing heavily in sustainability as well, adopting LED lighting, renewable energy, and organic pest control to meet growing environmental demands from consumers. These sustainable practices are emerging as critical differentiators in brand image and compliance, especially for larger producers targeting international exports. 

 

Recent News and Industry Developments in the Cannabis Market 

In the final quarter of 2024, the Cannabis Market saw notable momentum in product diversification. Cannabinol-based edibles surged in California, growing their retail share from just 4 percent in 2020 to over 25 percent by late 2024, reflecting a broadening appetite for novel cannabinoids among consumers. 

In early 2025, a major manufacturer completed the acquisition of a cannabis extraction facility to expand premium oil production and meet growing demand for vape products and concentrates, which are seeing double-digit growth across North America. 

October 2024 marked a significant cultural milestone as cannabis consumption among young women surpassed male consumption in many urban U.S. centers, encouraging leading brands to launch new beverage lines with tailored flavors and lower dosages aimed at this demographic. 

January 2025 brought positive signals for pharmaceutical-grade cannabis. The global cannabis pharmaceutical segment, driven by medical-grade extracts and GMP-certified production, is expected to scale from under four billion dollars in 2023 to nearly 380 billion dollars by 2034, creating a robust growth path for manufacturers aligned with the medical segment. 

In late 2024, a Canadian operator finalized the purchase of a specialized cannabis lab in Ontario, securing advanced terpene formulation capabilities. This acquisition is expected to support new product launches in both Europe and North America and reinforce a premium market position. 

 

“Cannabis Production Data and Cannabis Production Trend”

• • • • Cannabis sales database for historical years, 10 years historical data
      • Cannabis sales data and forecast for next 7 years

 

Key Insights that the Cannabis Market analysis report presents are:

• Cannabis Market revenue and demand by countries
• Break-down of the Cannabis Market in terms of application areas, target customers, and other potential market segments
• Areas that are relatively more potential and are faster growing
• Cannabis Market competitive scenario, market share analysis
• Cannabis Market business opportunity analysis

Global and Country-Wise Cannabis Market Statistics

• Global and Country-Wise Cannabis Market Size ($Million) and Forecast, till 2030
• Global and Country-Wise Cannabis Market Trend Analysis
• Global and Country-Wise Cannabis Market Business Opportunity Assessment